English  |  正體中文  |  简体中文  |  总笔数 :2853777  
造访人次 :  45282894    在线人数 :  751
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"su t h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 251-300 / 608 (共13页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-09-04T05:16:53Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:48Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Liu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:46Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:46Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:45Z Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:45Z High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:43Z Letter: hepatitis B virus infection and risk of multiple myeloma—a meta-analysis of cohort studies. Authors' reply Su T.-H.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:43Z Real-world effectiveness from the asia pacific rim liver consortium for hbv risk score for the prediction of hepatocellular carcinoma in chronic hepatitis b patients treated with oral antiviral therapy Yang H.-I.; Yeh M.-L.; Wong G.L.; Peng C.-Y.; Chen C.-H.; Trinh H.N.; Cheung K.-S.; Xie Q.; Su T.-H.; Kozuka R.; Lee D.-H.; Ogawa E.; Zhao C.; Ning H.-B.; Huang R.; Li J.; Zhang J.Q.; Ide T.; Xing H.; Iwane S.; Takahashi H.; Wong C.; Wong C.; Lin C.-H.; Hoang J.; Le A.; Henry L.; Toyoda H.; Ueno Y.; Gane E.J.; Eguchi Y.; Kurosaki M.; Wu C.; Liu C.; Shang J.; Furusyo N.; Enomoto M.; JIA-HORNG KAO; Yuen M.-F.; Yu M.-L.; Nguyen M.H.
臺大學術典藏 2021-09-04T05:16:41Z Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Su T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:41Z Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection Hsiao C.-Y.; Teng X.; Su T.-H.; Lee P.-H.; JIA-HORNG KAO; Huang K.-W.
臺大學術典藏 2021-09-04T05:16:40Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:39Z Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:38Z Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:37Z The clinical manifestations and management of COVID-19-related liver injury Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:37Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:37Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏 2021-09-04T05:16:29Z Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan Su H.-J.; JIA-HORNG KAO; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; Liu C.-J.
臺大學術典藏 2021-09-04T05:16:27Z High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:25Z Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan Liu C.-H.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:25Z Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:23Z Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling Hsiao C.-Y.; Teng X.; Su T.-H.; Lee P.-H.; JIA-HORNG KAO; Huang K.-W.
臺大學術典藏 2021-09-04T05:16:22Z APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients JIA-HORNG KAO; Jeng W.-J.; Ning Q.; Su T.-H.; Tseng T.-C.; Ueno Y.; Yuen M.-F.
臺大學術典藏 2021-09-04T05:16:22Z Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma Wu C.-H.; Liang P.-C.; Su T.-H.; Lin M.-C.; Chang Y.-H.; Shih T.T.-F.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:21Z Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:21Z Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy Su T.-H.; Hsu S.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:19Z Artificial intelligence in precision medicine in hepatology Su T.-H.; Wu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:18Z Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma Huang S.-C.; Liao S.-H.; Su T.-H.; Jeng Y.-M.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:18Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2021-08-20T07:38:56Z Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy Liu C.-H.; Sun H.-Y.; SZU-MIN HSIEH; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-08-20T07:10:54Z Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy Liu C.-H.; HSIN-YUN SUN; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-22T08:13:27Z Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers KAI-CHI CHANG; Chang M.-H.; Lee C.-N.; Chang C.-H.; Wu J.-F.; Ni Y.-H.; Wen W.-H.; Shyu M.-K.; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; Liu C.-J.; Chen D.-S.; Lin L.-H.; Chen H.-L.; Hwa H.-L.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Hsu H.-Y.; Chiu Y.-C.; Su T.-H.; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Zhao L.-L.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)
臺大學術典藏 2021-07-22T08:13:26Z Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate Wen W.-H.; Chen H.-L.; Shih T.T.-F.; Wu J.-F.; Ni Y.-H.; Lee C.-N.; Zhao L.-L.; Lai M.-W.; Mu S.-C.; Tung Y.-C.; Hsu H.-Y.; Chang M.-H.; Shyu M.K.; Hwa H.L.; Su Y.N.; Shih J.C.; Chao K.H.; Chiu Y.C.; KAI-CHI CHANG; Liu C.J.; Su T.H.; Chen D.S.; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)
臺大學術典藏 2021-07-22T06:25:02Z Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection CHIH-YANG HSIAO; Teng X.; Su T.-H.; Lee P.-H.; Kao J.-H.; Huang K.-W.
臺大學術典藏 2021-07-22T06:25:01Z Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling CHIH-YANG HSIAO; Teng X.; Su T.-H.; Lee P.-H.; Kao J.-H.; Huang K.-W.
臺大學術典藏 2021-07-22T03:35:53Z Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era Cheng C.-L.; Huang S.-C.; Chen J.-H.; Wei C.-H.; Fang W.-Q.; Su T.-H.; Yuan C.-T.; LIU JIA-HAU; Chuang M.-K.; Tien H.-F.
臺大學術典藏 2021-07-15T02:20:11Z Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate Wen W.-H.; HUEY-LING CHEN; Shih T.T.-F.; Wu J.-F.; Ni Y.-H.; Lee C.-N.; Zhao L.-L.; Lai M.-W.; Mu S.-C.; Tung Y.-C.; Hsu H.-Y.; Chang M.-H.; Shyu M.K.; Hwa H.L.; Su Y.N.; Shih J.C.; Chao K.H.; Chiu Y.C.; Chang K.C.; Liu C.J.; Su T.H.; Chen D.S.; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study); HUEY-LING CHEN
臺大學術典藏 2021-07-12T02:44:48Z Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection Su T.-H; | Liu C.-J; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Chen C.-L; | Chen P.-J; | Kao J.-H; | Chen D.-S.
臺大學術典藏 2021-07-12T02:44:46Z Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy Su T.-H; | Liu C.-J; | HUNG-CHIH YANG; | Jeng Y.-M; | Cheng H.-R; | Liu C.-H; | Tseng T.-C; | Ling T.-Y; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:41Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition Su T.-H; | Shiau C.-W; | Jao P; | Liu C.-H; | Liu C.-J; | Tai W.-T; | Jeng Y.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Huang H.-P; | Cheng H.-R; | Chen P.-J; | Chen K.-F; | Kao J.-H; | Chen D.-S.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H; | Shiau C.-W; | Jao P; | Yang N.-J; | Tai W.-T; | Liu C.-J; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-H; | Huang K.-W; | Hu T.-C; | Huang Y.-J; | Wu Y.-M; | Chen L.-J; | Chen P.-J; | Chen D.-S; | Chen K.-F; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:33Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Liou J.-M; | Liu C.-H; | Chen C.-L; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:31Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy Su T.-H; | Liao C.-H; | Liu C.-H; | Huang K.-W; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:28Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Chou S.-W; | Lin C.-H; | Liu C.-H; | Liu C.-J; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H; | Liao S.-H; | Hong C.-M; | Liu C.-J; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Adhoute X; | Bourli?re M; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:25Z Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Su T.-H; | Peng C.-Y; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.

显示项目 251-300 / 608 (共13页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目